Home > Quotes > AGN > Guru Analysis > James P. O'Shaughnessy

James P. O'Shaughnessy Guru Analysis for Allergan, Inc.

AGN 
$170.04
*  
0.16
0.09%
Get AGN Alerts
*Delayed - data as of Sep. 17, 2014  -  Find a broker to begin trading AGN now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time

Assessments & Analysis Based on September 16, 2014 close price: $170.2

  for the Growth/Value Investor based on the criteria of James P. O'Shaughnessy. Return to AGN Guru Analysis

All Star Guru Scorecard

Source Go Chart %
Peter Lynch 0%
Benjamin Graham 57%
Validea 71%
Motley Fool 59%
David Dreman 64%
Martin Zweig 62%
Kenneth Fisher 40%
James P. O'Shaughnessy 40%



Detailed Analysis

Guru Score: 40%


MARKET CAP: [PASS]

The first requirement of the Cornerstone Growth Strategy is that the company has a market capitalization of at least $150 million. This will screen out the companies that are too illiquid for most investors, but still include a small growth company. AGN, with a market cap of $50,581 million, passes this criterion.


EARNINGS PER SHARE PERSISTENCE: [FAIL]

The Cornerstone Growth methodology looks for companies that show persistent earnings growth without regard to magnitude. To fulfill this requirement, a company's earnings must increase each year for a five year period. AGN, whose annual EPS before extraordinary items for the last 5 years (from earliest to the most recent fiscal year) were $2.03, $0.00, $3.05, $3.57 and $4.20, fails this test.


PRICE/SALES RATIO: [FAIL]

The Price/Sales ratio should be below 1.5. This value criterion, coupled with the growth criterion, identify growth stocks that are still cheap to buy. Unfortunately, AGN's Price/Sales ratio of 7.49, based on trailing 12 month sales, fails this criterion.


RELATIVE STRENGTH: [FAIL]

The final criterion for the Cornerstone Growth Strategy requires that the Relative Strength of the company be among the top 50 of the stocks screened using the previous criterion. This gives you the opportunity to buy the growth stocks you are searching for just as the market is embracing them. AGN has a relative strength of 91. Therefore, it would fail not only the three previous required criterion but also the overall methodology.

 
The names of individual investment advisors (i.e., the 'gurus') appearing ON THIS WEBSITE are for identification purposes ONLY. The names are used to identify the methodology as derived from the guru's published sources. The names of the individual gurus are not intended to suggest or imply any affiliation with or endorsement of, or even any agreement with the information displayed on this website personally by such gurus, or any knowledge or approval by such persons of the content on this website. All trademarks, service marks and trade names appearing on this website are the property of their respective owners, and are likewise used for identification purposes only.

The NASDAQ Stock Market, Inc. ("NASDAQ"), its affiliates, third party information providers, or any of these entities' officers, employees, directors, or agents have not: (1) passed on the merit of the information provided on this website or on any of these securities; or (2) endorsed or sponsored any of these securities. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED. The information contained on this website is provided for informational purposes only. See Full Disclaimer Below
See Full Disclaimer